Elekta wins public tender to deliver advanced cancer care solutions to New Karolinska Solna (NKS)
Tomas Puusepp, Elekta’s President and CEO, says: “As a Swedish corporation headquartered in Stockholm, and as a world leader in cancer care, we are delighted to be awarded this prestigious tender. We are fully committed to investing in research and innovation and in providing our state-of-the-art technology in collaboration with NKS, in order to strengthen cancer care in the Stockholm region. It is exciting to further expand and deepen our collaboration with Karolinska (NKS), the hospital where stereotactic radiotherapy originated. Karolinska is a visionary and a great partner to Elekta’s own pioneering spirit in research, development and clinical advancement to support cancer care throughout the world.”
The agreement is expected to be formally signed during Elekta’s first fiscal quarter 2016/17 and the bulk of the installation will occur in April 2017. The final decision is pending a 10-day review process during which the decision can be appealed.
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on May 25, 2016.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.